Obesity Trials & Trends: Insights from Practicing Physician Investigators

Javara Launches LinkedIn Live Series

Javara has officially kicked off a series of LinkedIn Live events that will discuss an array of topics including obesity trials and trends, pediatrics, HCP relationships, DEI, site relationships with Sponsors and CROs, and much more.

Our first event featured three practicing investigators: Dr. Charlotte Grayson (Privia Health), Dr. Mollie Sourwine (also of Privia Health) and Dr. Sangeeta Wagner (Nevada Health Centers).

Led by Javara Medical Director Dr. Colleen Tenan, our esteemed panelists shared about all things obesity trials, from the evolving (and ever-increasing) demand for obesity medications, to the obstacles patients encounter in accessing such medicines.

Insights from Practicing Physician Investigators

Looking to trends to help navigate the future of obesity clinical trials, our guests also spoke to the value of patient awareness and greater understanding of the additional benefits these medications provide, highlighting the pivotal role of ongoing clinical trials in ensuring these medications reach the patients who need them most. They agreed, however, that partnership has been vital to their success, emphasizing how collaboration with Javara has enhanced patient retention for their clinical trials, fostering strong physician-patient relationships and fortifying the quality of clinical trial data. A full recording of this LinkedIn Live can be found below.

Be sure to follow us on LinkedIn and turn on notifications so you don’t miss the reveal of the next LinkedIn Live event! A special thank you to all three of our incredible panelists. It is because of you that this event was such an educational, successful event.